Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Descamps

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
AIDS (London, England)|June 1, 1997
A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunizationI P Coulaud, M L Gougeon, E Gomard, et al.
The Journal of Hospital Infection|December 9, 2022
SARS-CoV-2 viability and viral RNA persistence on microbiological agar platesE Farfour, S Lebourgeois, H R Chenane, et al.
Journal of Clinical Microbiology|March 21, 1998
Highly sensitive method for amplification of human immunodeficiency virus type 2 DNAF Damond, I Loussert-Ajaka, C Apetrei, et al.
Journal of Virology|October 29, 1997
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analysesD Descamps, G Collin, F Letourneur, et al.
Optics Express|March 17, 2021
High-order parametric generation of coherent XUV radiationO Hort, A Dubrouil, M A Khokhlova, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 9, 2020
Phylogenetic investigation of HCV-4d epidemic in Paris MSM HIV population reveals a still active outbreak and a strong link to the NetherlandsB Visseaux, S Hué, Q Le Hingrat, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2017
HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitorsE Alessandri-Gradt, G Collin, A Tourneroche, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatmentA G Marcelin, B Visseaux, M Wirden, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2008
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitroB Roquebert, F Damond, G Collin, et al.
Hepatology (Baltimore, Md.)|August 1, 1990
Predictive value of whole blood chemiluminescence in patients with alcoholic hepatitisF Lunel, B Descamps-Latscha, D Descamps, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
AIDS (London, England)|June 1, 1997
A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunizationI P Coulaud, M L Gougeon, E Gomard, et al.
The Journal of Hospital Infection|December 9, 2022
SARS-CoV-2 viability and viral RNA persistence on microbiological agar platesE Farfour, S Lebourgeois, H R Chenane, et al.
Journal of Clinical Microbiology|March 21, 1998
Highly sensitive method for amplification of human immunodeficiency virus type 2 DNAF Damond, I Loussert-Ajaka, C Apetrei, et al.
Journal of Virology|October 29, 1997
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analysesD Descamps, G Collin, F Letourneur, et al.
Optics Express|March 17, 2021
High-order parametric generation of coherent XUV radiationO Hort, A Dubrouil, M A Khokhlova, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 9, 2020
Phylogenetic investigation of HCV-4d epidemic in Paris MSM HIV population reveals a still active outbreak and a strong link to the NetherlandsB Visseaux, S Hué, Q Le Hingrat, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2017
HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitorsE Alessandri-Gradt, G Collin, A Tourneroche, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatmentA G Marcelin, B Visseaux, M Wirden, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2008
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitroB Roquebert, F Damond, G Collin, et al.
Hepatology (Baltimore, Md.)|August 1, 1990
Predictive value of whole blood chemiluminescence in patients with alcoholic hepatitisF Lunel, B Descamps-Latscha, D Descamps, et al.
Pageof 13